Figure 3From: Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoringConcentration ranges of proteins originating MPM candidate biomarker peptides detected through SRM-assays in serum. Reported are protein concentrations in serum/plasma available from the PeptideAtlas database [32] (red dots) (Additional file 7: Table S4). For comparison, cut-off levels of selected MPM biomarkers in serum/plasma proposed by the literature [11, 33–36] are reported (blue dots). Concentrations are reported in logarithmic scale.Back to article page